
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.38 | 1.60 | 0.22 |
Shares | 0.09 | 0.09 | 0.00 |
Bonds | 98.49 | 98.49 | 0.00 |
Convertible | 0.04 | 0.04 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.18 | 11.37 |
Price to Book | 1.81 | 2.01 |
Price to Sales | 2.17 | 0.99 |
Price to Cash Flow | - | 5.89 |
Dividend Yield | 4.90 | 3.65 |
5 Years Earnings Growth | - | 4.39 |
Name | Net % | Category Average |
---|---|---|
Corporate | 81.61 | 70.28 |
Government | 8.61 | 33.67 |
Municipal | 7.77 | 11.63 |
Cash | 1.38 | 16.95 |
Securitized | 0.51 | 5.98 |
Number of long holdings: 1,345
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Anheuser-Busch Companies LLC / Anheuser-Busch InBev Worldwide Inc | - | 1.29 | - | - | |
Microsoft Corp. | - | 0.74 | - | - | |
United States Treasury Bonds | - | 0.66 | - | - | |
United States Treasury Notes | - | 0.60 | - | - | |
JPMorgan Chase & Co. | - | 0.59 | - | - | |
Wells Fargo & Co. | - | 0.58 | - | - | |
Bristol-Myers Squibb Company | - | 0.55 | - | - | |
Comcast Corporation | - | 0.54 | - | - | |
AbbVie Inc. | - | 0.54 | - | - | |
Morgan Stanley | - | 0.54 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Bond Market II Index | 171.03B | 3.76 | 1.71 | 1.62 | ||
Vanguard Total Bond Market II Idx I | 153.93B | 3.71 | 1.64 | 1.55 | ||
Vanguard Target Retire Trust Plus35 | 127.95B | 9.12 | 10.89 | 8.21 | ||
The Vanguard Target Retire 2035 Tr1 | 127.95B | 9.12 | 10.88 | 8.20 | ||
The Vanguard Target Retire 2035 Tr2 | 127.95B | 9.11 | 10.88 | 8.19 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review